I-MAB (IMAB)
1.76
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
1.76
0.00 (0.00%)
After-Hours: 20:00
I-MAB Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2022 | -161.14M |
June 30, 2022 | -169.29M |
December 31, 2021 | -151.40M |
Date | Value |
---|---|
June 30, 2021 | -117.84M |
June 30, 2020 | -106.35M |
June 30, 2019 | -67.02M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-169.29M
Minimum
Jun 2022
-67.02M
Maximum
Jun 2019
-128.84M
Average
-134.62M
Median
Cash from Operations (TTM) Benchmarks
Summit Therapeutics Inc | -93.76M |
Verastem Inc | -94.48M |
CEL-SCI Corp | -20.13M |
AIM ImmunoTech Inc | -22.40M |
IGC Pharma Inc | -6.19M |